Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no changes to study details or user-facing functionality were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe government funding status banner was removed from the page. Core study content remains unchanged.SummaryDifference0.3%

- Check34 days agoChange DetectedNo substantive updates detected between the two screenshots; the study details, eligibility criteria, and locations appear unchanged.SummaryDifference0.3%

- Check63 days agoChange DetectedUpdated page version to v3.2.0 and added a government operating-status notice; removed mention of Medullary thyroid carcinoma under Genetic and Rare Diseases Information Center and old version v3.1.0.SummaryDifference3%

- Check70 days agoChange DetectedUpdate term from 'Medullary thyroid gland carcinoma' to 'Medullary thyroid carcinoma' and bump version from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check84 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2, indicating a version upgrade. The 'Back to Top' link was removed, with no other substantive changes to pricing, stock, times, or names.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.